Arrowhead Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US04280A1007
USD
60.77
4.1 (7.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
829.45
3.55
240.74
243.23
138.29
87.99
168.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
829.45
3.55
240.74
243.23
138.29
87.99
168.80
Raw Material Cost
23.93
18.59
12.49
10.42
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
204.37
197.97
174.80
189.47
130.53
81.46
36.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
89.36
32.35
18.33
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
121.92
96.82
90.93
122.82
80.08
51.66
26.54
Other Expenses
29.15
25.89
14.92
9.90
6.84
4.21
3.99
Total Expenditure (Excl Depreciation)
731.10
604.63
445.74
421.74
279.06
175.21
103.17
Operating Profit (PBDIT) excl Other Income
98.3
-601.1
-205
-178.5
-140.8
-87.2
65.6
Other Income
42.55
20.97
16.84
5.80
8.19
8.61
6.96
Operating Profit (PBDIT)
164.82
-561.51
-175.67
-162.29
-132.58
-78.61
72.59
Interest
89.36
32.35
18.33
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
805.52
-15.04
228.24
232.81
0.00
0.00
0.00
Depreciation
23.93
18.59
12.49
10.42
8.27
5.94
4.44
Profit Before Tax
51.53
-612.46
-206.49
-172.71
-140.85
-84.55
68.15
Tax
21.42
-2.77
2.78
3.79
0.00
0.00
0.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1.63
-599.49
-205.28
-176.06
-140.85
-84.55
67.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1.63
-599.49
-205.28
-176.06
-140.85
-84.55
67.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
31.75
-10.20
-4.00
-0.43
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.11
-609.69
-209.28
-176.49
-140.85
-84.55
67.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
466.05
185.44
271.34
398.52
408.82
461.78
244.59
Earnings per share (EPS)
-0.01
-5.0
-1.92
-1.67
-1.36
-0.84
0.69
Diluted Earnings per share
-0.01
-5.0
-1.92
-1.67
-1.36
-0.84
0.69
Operating Profit Margin (Excl OI)
11.86%
-16927.06%
-85.16%
-73.39%
-107.77%
-105.87%
36.25%
Gross Profit Margin
9.1%
-16723.88%
-80.59%
-66.72%
-95.87%
-89.34%
43.0%
PAT Margin
-0.2%
-16882.37%
-85.27%
-72.39%
-101.85%
-96.09%
40.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2025 is 22,938.89% vs -98.50% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Sep 2025 is 104.94% vs -191.30% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2025 is 121.00% vs -202.60% in Sep 2024

stock-summary

Interest

YoY Growth in year ended Sep 2025 is 175.93% vs 77.05% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Sep 2025 has improved from Sep 2024

Compare Annual Results Of Arrowhead Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
829.45
12.44
817.01
6,567.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
829.45
12.44
817.01
6,567.60%
Raw Material Cost
23.93
3.53
20.40
577.90%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
204.37
0.00
204.37
Power Cost
0
0
0.00
Manufacturing Expenses
89.36
0.00
89.36
Selling and Distribution Expenses
121.92
239.80
-117.88
-49.16%
Other Expenses
29.15
52.87
-23.72
-44.86%
Total Expenditure (Excl Depreciation)
731.10
772.03
-40.93
-5.30%
Operating Profit (PBDIT) excl Other Income
98.35
-759.59
857.94
112.95%
Other Income
42.55
19.23
23.32
121.27%
Operating Profit (PBDIT)
164.82
-737.43
902.25
122.35%
Interest
89.36
0.00
89.36
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
805.52
8.91
796.61
8,940.63%
Depreciation
23.93
2.93
21.00
716.72%
Profit Before Tax
51.53
-740.36
791.89
106.96%
Tax
21.42
0.51
20.91
4,100.00%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
-1.63
-740.87
739.24
99.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1.63
-740.87
739.24
99.78%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
31.75
0.00
31.75
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.11
-740.87
770.98
104.06%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
466.05
996.52
-530.47
-53.23%
Earnings per share (EPS)
-0.01
-13.18
13.17
99.92%
Diluted Earnings per share
-0.01
-13.18
13.17
99.92%
Operating Profit Margin (Excl OI)
11.86%
-6,107.98%
0.00
6,119.84%
Gross Profit Margin
9.10%
-5,929.80%
0.00
5,938.90%
PAT Margin
-0.20%
-5,957.44%
0.00
5,957.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 82.94 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 22,938.89% vs -98.50% in Sep 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 3.01 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 104.94% vs -191.30% in Sep 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.23 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 121.00% vs -202.60% in Sep 2024

Annual - Interest
Interest 8.94 Million
in Sep 2025

Figures in Million
stock-summary

YoY Growth in year ended Sep 2025 is 175.93% vs 77.05% in Sep 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.86%
in Sep 2025

Figures in %
stock-summary

YoY Growth in year ended Sep 2025 has improved from Sep 2024